Telix Links 29 US Radiopharmacies to Global Dose Production Network
Melbourne – October 21, 2026 -- Telix Manufacturing Solutions (TMS) runs seven facility groups across North America, Europe and Asia Pacific, anchored by 29 accredited radiopharmacies in the United States, to deliver radiopharmaceutical doses to patients before the products decay. The short half-life of these products makes efficient manufacturing and logistics a prerequisite for timely delivery.
RLS network delivers patient doses from 29 U.S. sites
The RLS Radiopharmacies network is accredited by The Joint Commission. Each site is staffed by Nuclear Pharmacists, Radiation Safety Officers and a dedicated courier fleet.
Seneffe and Yokohama anchor commercial supply in Europe and Asia Pacific
TMS Seneffe, in Belgium's RadioPharma Valley, is one of the largest GMP production facilities of its kind in Europe and Telix's primary manufacturing site for the region. It includes a dedicated laboratory for alpha therapies.